Prediction of chemotherapy benefit for colon cancers
- PMID: 26831289
- DOI: 10.1016/S1470-2045(16)00068-1
Prediction of chemotherapy benefit for colon cancers
Comment on
-
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.N Engl J Med. 2016 Jan 21;374(3):211-22. doi: 10.1056/NEJMoa1506597. N Engl J Med. 2016. PMID: 26789870 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
